Altimmune, Inc. (ALT) stock
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.65+0.03 (+2.17%)
Close on Nov 13, 2026Market cap $319.98MP/E –Yield –
Altimmune cash
Cash and short-term investments held at the end of each period.
Altimmune's cash was $265.06M at Sep 30, 2026. For fiscal 2025 it was $273.46M, up 107.3% from the year before. Over ten years it grew 50.3% a year on average. The highest annual figure on record is $273.46M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.46M | +107.3% |
| FY2024 | Dec 31, 2024 | $131.93M | -33.3% |
| FY2023 | Dec 31, 2023 | $197.86M | +7.0% |
| FY2022 | Dec 31, 2022 | $184.91M | -2.8% |
| FY2021 | Dec 31, 2021 | $190.34M | -11.9% |
| FY2020 | Dec 31, 2020 | $215.96M | +479.4% |
| FY2019 | Dec 31, 2019 | $37.27M | +8.5% |
| FY2018 | Dec 31, 2018 | $34.35M | +179.2% |
| FY2017 | Dec 31, 2017 | $12.30M | -94.4% |
| FY2016 | Dec 31, 2016 | $220.81M | +4660.1% |
| FY2015 | Dec 31, 2015 | $4.64M | -75.1% |
| FY2014 | Dec 31, 2014 | $18.64M | +77.9% |
| FY2013 | Dec 31, 2013 | $10.48M | -17.5% |
| FY2012 | Dec 31, 2012 | $12.70M | +13.0% |
| FY2011 | Dec 31, 2011 | $11.24M | -4.7% |
| FY2010 | Dec 31, 2010 | $11.79M | +340.8% |
| FY2009 | Dec 31, 2009 | $2.67M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $265.06M | +25.7% |
| Q2 FY2026 | Jun 30, 2026 | $326.28M | +78.2% |
| Q1 FY2026 | Mar 31, 2026 | $331.54M | +121.2% |
| Q4 FY2025 | Dec 31, 2025 | $273.46M | +107.3% |
| Q3 FY2025 | Sep 30, 2025 | $210.82M | +51.2% |
| Q2 FY2025 | Jun 30, 2025 | $183.15M | +11.0% |
| Q1 FY2025 | Mar 31, 2025 | $149.87M | -17.7% |
| Q4 FY2024 | Dec 31, 2024 | $131.93M | -33.3% |
| Q3 FY2024 | Sep 30, 2024 | $139.42M | -1.0% |
| Q2 FY2024 | Jun 30, 2024 | $164.95M | +3.1% |
| Q1 FY2024 | Mar 31, 2024 | $182.07M | +9.8% |
| Q4 FY2023 | Dec 31, 2023 | $197.86M | +7.0% |
| Q3 FY2023 | Sep 30, 2023 | $140.82M | -30.2% |
| Q2 FY2023 | Jun 30, 2023 | $160.00M | -13.4% |
| Q1 FY2023 | Mar 31, 2023 | $165.76M | -7.9% |
| Q4 FY2022 | Dec 31, 2022 | $184.91M | -2.8% |
| Q3 FY2022 | Sep 30, 2022 | $201.86M | +1.0% |
| Q2 FY2022 | Jun 30, 2022 | $184.79M | -15.2% |
| Q1 FY2022 | Mar 31, 2022 | $179.98M | -20.6% |
| Q4 FY2021 | Dec 31, 2021 | $190.34M | -11.9% |
| Q3 FY2021 | Sep 30, 2021 | $199.92M | -3.3% |
| Q2 FY2021 | Jun 30, 2021 | $217.86M | +171.4% |
| Q1 FY2021 | Mar 31, 2021 | $226.54M | +587.5% |
| Q4 FY2020 | Dec 31, 2020 | $215.96M | +479.4% |
| Q3 FY2020 | Sep 30, 2020 | $206.81M | +427.1% |
| Q2 FY2020 | Jun 30, 2020 | $80.26M | +92.4% |
| Q1 FY2020 | Mar 31, 2020 | $32.95M | -26.7% |
| Q4 FY2019 | Dec 31, 2019 | $37.27M | +8.5% |
| Q3 FY2019 | Sep 30, 2019 | $39.23M | +390.5% |
| Q2 FY2019 | Jun 30, 2019 | $41.71M | +775.7% |
| Q1 FY2019 | Mar 31, 2019 | $44.94M | +455.2% |
| Q4 FY2018 | Dec 31, 2018 | $34.35M | +179.2% |
| Q3 FY2018 | Sep 30, 2018 | $8.00M | -53.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.76M | -43.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.09M | +195.7% |
| Q4 FY2017 | Dec 31, 2017 | $12.30M | -94.4% |
| Q3 FY2017 | Sep 30, 2017 | $17.15M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $220.81M | – |
See a number that looks wrong?